• Breaking News

    Sunday, November 7, 2021

    Stock Market - TSLA - time to VOTE!

    Stock Market - TSLA - time to VOTE!


    TSLA - time to VOTE!

    Posted: 07 Nov 2021 05:28 AM PST

    Elon Musk faces a $15 billion tax bill, which is likely the real reason he's selling stock

    Posted: 07 Nov 2021 02:27 PM PST

    Its sunday here in Germany, people can trade for a couple of hours. Have a look at Tesla. Already dipping hard

    Posted: 07 Nov 2021 10:10 AM PST

    Danger ahead

    Posted: 07 Nov 2021 03:19 AM PST

    TSLA: Post your projected market close for this Friday below

    Posted: 07 Nov 2021 02:41 PM PST

    We're here to Fu¢k $hit up

    Posted: 07 Nov 2021 04:11 PM PST

    Next Week's Economic Calendar 11.08.2021 - 11.15.2021

    Posted: 07 Nov 2021 07:19 PM PST

    Stocks could soar to new heights in week ahead — even though inflation data may come in hot

    Posted: 07 Nov 2021 11:24 AM PST

    How Warren Buffett and Charlie Munger invested when they had small capital

    Posted: 07 Nov 2021 06:18 AM PST

    �� EV maker Rivian boosts IPO price range, aims for $65 bln valuation

    Posted: 07 Nov 2021 04:36 PM PST

    THESE STOCKS SHOULD BE IN YOUR PORTFOLIO BEFORE NOVEMBER ENDS ($LAC, $CIDM, $REKR, $WTER)

    Posted: 07 Nov 2021 07:28 PM PST

    How Bitcoin Has Performed Compared To Top Stocks

    Posted: 07 Nov 2021 05:25 PM PST

    HOW TO PLAY $RIVN IPO

    Posted: 07 Nov 2021 05:06 PM PST

    An Inconvenient Truth: How Tesla Became a Trillion-Dollar Company

    Posted: 07 Nov 2021 06:20 AM PST

    What was the story on newegg? It flew from $10 to $70+ within 1 1/2 weeks and fell all the way back down to it's price before it's boom.

    Posted: 06 Nov 2021 10:14 PM PDT

    AQST POTENTIAL GREAT STOCK HERES WHY PDUFA DEC 23.

    Posted: 07 Nov 2021 09:01 AM PST

    AQST POTENTIAL GREAT STOCK HERES WHY PDUFA DEC 23.

    $AQST – Aquestive Therapeutics inc.

    PDUFA DECEMBER 23RD 2021, LIBERVANT

    Price Currently $5.14

    All time high $19.

    Last Pdufa run $9. 2nd time around much better chances. PLEASE SEE PHOTO OF CHART

    https://preview.redd.it/l85hmmyrf7y71.jpg?width=1125&format=pjpg&auto=webp&s=889aea37aabb645d8840c6482909391bd6ec4f1e

    I am in not in any way any type financial advisor this is just my opinion for a company that I believe has a lot to offer.

    Just to keep it simple for us here is the run down why I think this particular stock could possibly make a strong run and possibly even a potential Buy Out / Partnership in the making.

    - AQST PharmaFilm Technology to sum it all up just Imagine of eliminating all oral pills, gels, injections etc. and making it a mouth strip exactly similar to Listerine Pocket Packs for fresh breath. The film could be dissolved on your tongue, cheek etc. without all the toxins hurting your liver and body parts. Furthermore, it would even be effective faster. This is the delivery system AQST has been able to create. Putting drugs on film would benefits millions and millions of people. Its Geniusssssss!!!!!!

    - MonoSol Rx which was Aquestive Therapeutics former name announced a Licensing Agreement back on Oct 06, 2016 with Lupin Pharmaceutical Inc. for multiple pediatric-focused products. Hmmm think about all the kids that don't like to take pills and medications in traditional delivery forms, just being able dissolve a film on their tongue. GAMECHANGER here, imagine how much this would help.

    - AQST has 5 products already approved by the FDA so Dec 23rd Pdufa date is something familiar to them. The company continues to report encouraging numbers for SYMPAZAN and they recently also announced a supply agreement with Mitsubishi Tanabe Pharma to commercialize EXSERVAN in the United States.

    - AQST just reported Positive Topline Data from Phase 1 trail of AQST-109, the first and only orally delivered epinephrine product candidate. It demonstrated clinical results comparable to auto injectors. THIS could replace the EpiPen this is hugeeeeee!!!!!!!!

    AQST had a PDUFA for Libervant in September 2020, however they received a CRL from the FDA and then completed a Type A meeting with FDA November 2020. Furthermore, they received further guidance from the FDA in FEBURARY 2021, giving them 2 appearances with the FDA to guide them in the right direction.

    AQST stated based upon the Agency's guidance, the submission included additional statistical modeling and supporting analyses of the existing clinical data. The company continues to believe that no additional clinical studies will be required for FDA approval of LIBERVANT for U.S. market access.

    I wish AQST the best and hope they continue to get FDA approvals to prove how strong their delivery system is. Again, please do your due diligence this is just my opinion. I have asked a few other members that's are knowledgeable about the company to post also.

    submitted by /u/Snoo65776
    [link] [comments]

    -1,054.55% Pay out ratio? (XOM) is this accurate?

    Posted: 07 Nov 2021 02:32 PM PST

    Southwestern to buy natural gas producer GEP Haynesville for $1.85 bln

    Posted: 07 Nov 2021 10:45 AM PST

    How do I find great value stocks with a simple screener?

    Posted: 07 Nov 2021 01:59 AM PST

    Sen. Pat Toomey (R., Pa.), ranking member on the Senate Banking Committee, recently introduced a bill to "preserve payment for order flow" and prohibit the SEC from banning the practice.

    Posted: 06 Nov 2021 09:27 PM PDT

    No comments:

    Post a Comment